Beclometason/Formoterol Stada

Beclometasone/Formoterol Stada is a combination medication used for managing asthma and chronic obstructive pulmonary disease (COPD). It combines an anti-inflammatory corticosteroid with a long-acting bronchodilator to improve breathing.

Beclometasone/Formoterol Stada is primarily used for the maintenance treatment of asthma and COPD. The beclometasone component helps reduce inflammation in the airways, while formoterol acts as a bronchodilator to relax the muscles around the airways. This combination can help manage symptoms such as wheezing, shortness of breath, and coughing. It is often prescribed for long-term control rather than for immediate relief of acute symptoms.

Common effects of Beclometasone/Formoterol Stada may include throat irritation, hoarseness, and a dry mouth. Some users might experience tremors, headaches, or an increased heart rate. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Beclometasone/Formoterol Stada should be used as directed by a healthcare provider. It is important to rinse the mouth after each use to minimize the risk of throat irritation and fungal infections. Patients with certain medical conditions, such as heart disease or diabetes, should use this medication with caution. Always inform your healthcare provider about any other medications you are taking.

Beclometasone/Formoterol Stada may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is also important to avoid using other inhaled medications without consulting a healthcare provider. Alcohol and other substances that can affect the respiratory system should be used with caution while taking this medication.